GlassScriptPhysician profile
Rowza Tur Rumma
NPI 1831585397
$1,736.12
in general payments reported to CMS, 2019-2025
11 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $583 · 2024: $150 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.28 |
| Education | $221.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $380.33 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $376.14 | 2023-2024 | Endurant Iis |
| Lemaitre Vascular, INC. | $202.87 | 2025 | Hydro Lemaitre Valvulotome |
| Cook Medical LLC | $167.99 | 2025 | Zilver Ptx, Rosen, Zenith Spiral-Z |
| Shockwave Medical, INC | $166.29 | 2025 | |
| Inari Medical, INC. | $141.80 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $123.82 | 2023-2024 | Azur Cx Detachable, Metacross Otw, Glidewire |
| Penumbra, INC. | $83.31 | 2025 | Indigo System, Ruby Coil |
| Centerline Biomedical INC. | $41.56 | 2025 | |
| Stryker Corporation | $31.37 | 2025 | Flowtriever |
| Teleflex LLC | $20.64 | 2025 | Quikclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rowza Rumma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.